Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) has become a major cause of liver transplantation and liver-associated death. Targeting the gut–liver axis is a potential therapy for NASH. The Fufang Zhenzhu Tiaozhi (FTZ) capsule, a traditional Chinese medicine commonly used in clinical practice, has recently em...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Tian, Xu, Tonghao, Fu, Yanfang, Jiang, Shuo, Liang, Xiaolin, Yu, Ze, Pan, Linyu, Rong, Xianglu, Guo, Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243428/
https://www.ncbi.nlm.nih.gov/pubmed/35784533
http://dx.doi.org/10.3389/fendo.2022.864703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243428/
https://www.ncbi.nlm.nih.gov/pubmed/35784533
http://dx.doi.org/10.3389/fendo.2022.864703

Ejemplares similares